Lilly presents trial data on Alzheimer's drug showing promise
Eli Lilly & Co. presented highly anticipated details from a mid-stage study showing that its experimental drug modestly slowed Alzheimer's disease progression over about 18 months.
Mar 15, 2021
0
2